Oman is globally acknowledged for its well-structured immunization program with high
vaccination coverage. The massive spread of misinformation brought on by the COVID-19 …

Despite the advances in the management of thalassemia major, heart disease remains the
leading cause of mortality in patients afflicted with this disorder. Cardiac involvement in …

Objective: Unusual clinical course Background: The COVID-19 pandemic is an ongoing
cause of the current global healthcare crisis. Several vaccines were approved for use by …

Despite the apparent challenges inflicted by COVID-19 globally, the pandemic provided an
opportunity to utilize and expand existing public health capacities for a more adaptive and …

Background COVID-19’s emergence carries with it many uncertainties and challenges,
including strategies to manage the epidemic. Oman has implemented non-pharmaceutical …

Background Anticoagulation with unfractionated heparin (UFH) or low molecular weight heparin
(LMWH) is the mainstay for the treatment of patients with acute cerebral vein thrombosis …

Objective To assess the seroprevalence of severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) in Oman and longitudinal changes in antibody levels over time within the …

Vaccination with ChAdOx1 nCov‐19 can result in vaccine‐induced immune thrombotic
thrombocytopenia (VITT). This phenomenon mimics heparin‐induced thrombocytopenia (HIT), …

Background Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
and pulmonary embolism (PE), is a known cause of morbidity and mortality after bariatric …

Objectives The study aimed to assess COVID-19 impact on the morbidity and mortality of
vasooclusive crisis (VOC) in sickle cell anaemia (SCA) patients. Methods A prospective cohort …